Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.17 USD | -5.83% | -4.59% | +47.00% |
20/05 | Nurix Therapeutics Names New Board Chair | MT |
14/05 | Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target | MT |
ETFs positioned on Nurix Therapeutics, Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.70% | 0 M€ | 0.00% | - | |
0.08% | 115 M€ | +4.22% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +8.16% | - | |
0.01% | 9 M€ | +9.29% | - | |
0.01% | 9 M€ | -.--% | - | |
0.00% | 746 M€ | -.--% | - | |
0.00% | 17 M€ | +4.66% | - | |
0.00% | 34 M€ | +3.53% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.00% | 956M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- NRIX Stock
- Funds and ETFs Nurix Therapeutics, Inc.